
Danish pharmaceutical company Lundbeck's top management was rewarded with decent pay raises in 2020, which late in the year cast off significantly more profits than analysts forecast – and more, even, than the same period in the year before.
Lundbeck's CEO Deborah Dunsire's salary, however, significantly changed from one year to the next: In 2020, less than half her 2019 pay went into her bank account.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app